Georg Schett Selected Research

Arthritis (Polyarthritis)

09/2008	The role of Wnt proteins in arthritis.
01/2008	Differentially regulated expression of growth differentiation factor 5 and bone morphogenetic protein 7 in articular cartilage and synovium in murine chronic arthritis: Potential importance for cartilage breakdown and synovial hypertrophy.
12/2007	The Rheumatoid Arthritis-Associated Autoantigen hnRNP-A2 (RA33) Is a Major Stimulator of Autoimmunity in Rats with Pristane-Induced Arthritis.
01/2006	Imbalance of local bone metabolism in inflammatory arthritis and its reversal upon tumor necrosis factor blockade: direct analysis of bone turnover in murine arthritis.
05/2005	Additive bone-protective effects of anabolic treatment when used in conjunction with RANKL and tumor necrosis factor inhibition in two rat arthritis models.
05/2005	Listeria-associated arthritis in a patient undergoing etanercept therapy: case report and review of the literature.
07/2004	Zoledronic acid protects against local and systemic bone loss in tumor necrosis factor-mediated arthritis.
02/2004	Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis.
01/2004	Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
01/2003	The role of osteoprotegerin in arthritis.

10	Arthritis (Polyarthritis) 09/2008 - 01/2003
8	Rheumatoid Arthritis 10/2008 - 12/2003
3	Fibrosis (Cirrhosis) 07/2008 - 01/2007
3	Systemic Scleroderma (Systemic Sclerosis) 05/2008 - 12/2007
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2007 - 05/2004
1	Mixed Connective Tissue Disease (MCTD) 08/2008
1	Pulmonary Fibrosis (Hamman Rich Syndrome) 08/2008
1	Polyneuropathies (Polyneuropathy) 06/2008
1	Rheumatic Diseases (Rheumatism) 05/2008
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2008
1	Hypertrophy 01/2008
1	Anoxia (Hypoxia) 12/2007
1	Vascular Diseases (Vascular Disease) 11/2006
1	Carotid Artery Diseases 12/2005
1	Bone Resorption 12/2005
1	Inflammation 05/2005
1	Necrosis 01/2005
1	Atherosclerosis (Atheroma) 05/2004
1	Osteitis 01/2004

7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2006 - 12/2003
4	OsteoprotegerinIBA 11/2006 - 01/2003
3	CytokinesIBA 06/2007 - 06/2005
2	imatinib (Gleevec)FDA Link 08/2008 - 01/2007
2	AutoantibodiesIBA 05/2008 - 12/2005
2	Interleukin-1 (Interleukin 1)IBA 01/2004 - 12/2003
1	Antirheumatic Agents (DMARD)IBA 10/2008
1	Wnt ProteinsIBA 09/2008
1	4- methyl- N- (3- (4- methylimidazol- 1- yl)- 5- (trifluoromethyl)phenyl)- 3- ((4- pyridin- 3- ylpyrimidin- 2- yl)amino)benzamide (nilotinib)FDA Link 07/2008
1	dasatinib (BMS 354825)FDA Link 07/2008
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 07/2008
1	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2008
1	src-Family KinasesIBA 05/2008
1	AntigensIBA 05/2008
1	pristane (pristan)IBA 12/2007
1	Extracellular Matrix ProteinsIBA 12/2007
1	RANK LigandIBA 07/2007
1	Protein Isoforms (Isoforms)IBA 09/2006
1	p38 Mitogen-Activated Protein KinasesIBA 09/2006
1	Heme Oxygenase-1IBA 12/2005
1	Chaperonin 60IBA 12/2005
1	I-kappa B KinaseIBA 05/2005
1	TNFR-Fc fusion protein (etanercept)FDA Link 05/2005
1	Mitogen-Activated Protein KinasesIBA 01/2005
1	zoledronic acid (zoledronate)FDA Link 07/2004
1	Parathyroid Hormone (Parathormone)IBA 02/2004